Rafferty Asset Management’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Sell |
109,807
-11,581
| -10% | -$243K | 0.01% | 569 |
|
|
2025
Q1 | $1.99M | Buy |
121,388
+3,161
| +3% | +$51.8K | 0.01% | 581 |
|
|
2024
Q4 | $3.04M | Sell |
118,227
-7,792
| -6% | -$200K | 0.01% | 520 |
|
|
2024
Q3 | $3.99M | Sell |
126,019
-5,077
| -4% | -$161K | 0.01% | 468 |
|
|
2024
Q2 | $4.6M | Sell |
131,096
-70,195
| -35% | -$2.46M | 0.02% | 438 |
|
|
2024
Q1 | $8.83M | Buy |
201,291
+7,935
| +4% | +$348K | 0.03% | 315 |
|
|
2023
Q4 | $6.88M | Buy |
193,356
+64,280
| +50% | +$2.29M | 0.03% | 375 |
|
|
2023
Q3 | $3.48M | Buy |
129,076
+4,059
| +3% | +$110K | 0.02% | 473 |
|
|
2023
Q2 | $2.94M | Sell |
125,017
-2,616
| -2% | -$61.5K | 0.02% | 534 |
|
|
2023
Q1 | $1.75M | Sell |
127,633
-26,630
| -17% | -$366K | 0.01% | 648 |
|
|
2022
Q4 | $2.8M | Buy |
154,263
+42,144
| +38% | +$766K | 0.02% | 499 |
|
|
2022
Q3 | $1.67M | Buy |
112,119
+67,952
| +154% | +$1.01M | 0.02% | 551 |
|
|
2022
Q2 | $610K | Sell |
44,167
-64,772
| -59% | -$895K | 0.01% | 769 |
|
|
2022
Q1 | $1.22M | Buy |
108,939
+2,234
| +2% | +$25K | 0.01% | 738 |
|
|
2021
Q4 | $2.52M | Buy |
106,705
+75,230
| +239% | +$1.78M | 0.01% | 583 |
|
|
2021
Q3 | $802K | Buy |
+31,475
| New | +$802K | 0.01% | 924 |
|